Startup India Government of India
Mericana Pharmaceuticals Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.65 Cr
▼ 43% YoY
Net profit · FY 2025
₹3.97 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹11.59 Lakh
EBITDA margin 3.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
4
As per MCA filings
About Mericana Pharmaceuticals Private Limited
Data last updated:
Mericana Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U33110MP2019PTC048220. Its GSTIN is 23AAMCM5616P1ZZ (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Suresh Kshirsagar and Gaurav Kshirsagar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O – Suresh Kshirsagar 556 Usha Nagar Extension, Indore, Madhya Pradesh, India – 452009.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.65 Cr, a decline of 43% compared to the previous year. For the same year it recorded a net profit of ₹3.97 Lakh (net margin 1.1%) and EBITDA of ₹11.59 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 3% over five years.
The company is associated with 1 brand: Mericanapharma. As per MCA filings, the company has open charges of ₹1 Cr on record.
Mericana Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0042993). For more details, the company can be reached via its website mericanapharma.com.
Company details
CIN U33110MP2019PTC048220
Registration Number 048220
Incorporation Date 29 March 2019
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0042993
Recognitions & Rankings of Mericana Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0042993
Contact details
Mericana Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh. Its website is mericanapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC/O – Suresh Kshirsagar 556 Usha Nagar Extension, Indore, Madhya Pradesh, India – 452009
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mericana Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Mericana Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Mericana Pharmaceuticals operates one associated brand: Mericanapharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers affordable pharmaceutical products and services for global community. | mericanapharma.com |
Business activity
The main business activity of Mericana Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mericana Pharmaceuticals Private Limited, buy the company report.
Financials of Mericana Pharmaceuticals Private Limited
FY 2023 filings availableMericana Pharmaceuticals Private Limited reported revenue of ₹3.65 Cr (down 43% YoY) for FY 2025.
Revenue · FY 2025
₹3.65 Cr ▼ 43%
Net profit · FY 2025
₹3.97 Lakh margin 1.1%
EBITDA · FY 2025
₹11.59 Lakh margin 3.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 43%
3 years · compounded
▼ 8%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 82%
3 years · compounded
▼ 48%
5 years · compounded
▼ 30%
Revenue fell 43% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.59 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.97 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mericana Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mericana Pharmaceuticals Private Limited
Mericana Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kshirsagar | Director | 29 Mar 2019 | 7 Years 6 Months | Current |
| Gaurav Kshirsagar Also directs: Welltek Lifesciences Private Limited | Director | 24 Sep 2020 | 6 Years 0 Months | Current |
| Priyesh Kumar Sinha Also directs: Welltek Lifesciences Private Limited | Director | 24 Sep 2020 | 6 Years 0 Months | Current |
| Madan Kumar Sinha | Director | 29 Mar 2019 | 7 Years 6 Months | Current |
Auditor
Mericana Pharmaceuticals Private Limited is audited by J K C & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J K C & COMPANY | FY 2023 | 030899N |
Shareholding
The shareholding of Mericana Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Mericana Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Dec 2024 | 101031429 | Hdfc Bank Limited | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Mericana Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mericana Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mericana Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAMCM5616P1ZZ | Madhya Pradesh | Active | 14 May 2019 |
To see the full GST registrations and return filing status of Mericana Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mericana Pharmaceuticals Private Limited has 6 board changes on record since 2019: 4 appointments and 2 cessations. The latest: Gaurav Kshirsagar ceased to be Additional Director on 30 Dec 2020.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 100.00 Lakh with Charge ID 101031429 was registered on 23 Dec 2024.
AGM
Mericana Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Mericana Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Gwalior.
Ceased
Gaurav Kshirsagar ceased to be Additional Director.
Ceased
Priyesh Kumar Sinha ceased to be Additional Director.
Appointed
Gaurav Kshirsagar was appointed as Director.
Appointed
Priyesh Kumar Sinha was appointed as Director.
Appointed
Madan Kumar Sinha was appointed as Director.
Appointed
Suresh Kshirsagar was appointed as Director.
Incorporation
29 Mar 2019
Mericana Pharmaceuticals Private Limited was registered on 29 Mar 2019 with Roc Gwalior & aged 7 years 6 months as per MCA records.
Frequently asked questions
Mericana Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 March 2019 (7+ years old) and is registered under CIN U33110MP2019PTC048220.
Mericana Pharmaceuticals has 4 current directors:
- Suresh Kshirsagar - Director
- Gaurav Kshirsagar - Director
- Priyesh Kumar Sinha - Director
- Madan Kumar Sinha - Director
The latest financial statements of Mericana Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Mericana Pharmaceuticals is 23AAMCM5616P1ZZ, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Mericana Pharmaceuticals is U33110MP2019PTC048220. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mericana Pharmaceuticals was incorporated on 29 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
Gaurav Kshirsagar ceased to be Additional Director on 30 Dec 2020. Priyesh Kumar Sinha ceased to be Additional Director on 30 Dec 2020. Gaurav Kshirsagar was appointed as Director on 24 Sep 2020. Mericana Pharmaceuticals has 6 board changes on record in total.
Yes, Mericana Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Mericana Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0042993).
Mericana Pharmaceuticals can be reached through the website mericanapharma.com. Its registered office is in Indore, Madhya Pradesh, India.